The global plasma therapy market comprises various types of platelet-rich plasma that are used by hospitals & clinics and several research institutions.
Rise in the number of orthopedic disorders associated with trauma and aging led to the increased demand for minimally-invasive therapies. This has further contributed to the increased demand for PRP in orthopedic, dermatology, nerve injury, cardiac muscle injury, and dental applications.
Download FREE Brochure @ https://tinyurl.com/y774no7j
This market is driven by several factors such as prevalence of orthopedic disorders such as arthritis and increase in healthcare expenditure. On the other hand, stringent regulatory policies and lack of awareness about platelet-rich therapy are factors restraining the growth of the expected to grow from USD 135.6 Million in 2016 to USD 297.6 Million by 2021, at a CAGR of 14.0% during the forecast period.
On the basis of type, the plasma therapy market is segmented into pure PRP, leucocyte-rich PRP, pure platelet-rich fibrin (PRF), and leukocyte-rich fibrin (L-PRF). The pure PRP segment is estimated to account for the largest share of the global market in 2016. Whereas, the leucocyte-rich PRP segment of the market is expected to grow at the highest CAGR from 2016 to 2021.
Based on source, the plasma therapy market is segmented into autologous and allogenic. The autologous segment is estimated to account for the largest share of the global market in 2016. Prevalence of orthopedic disorders such as arthritis and tendinitis has propelled the demand for advanced treatment options and development of minimally-invasive therapies. This in turn has contributed to the growth of the market.
Based on application, the market is segmented into dermatology, cardiac muscle injury, dental, nerve injury, and others. The orthopedic segment is further segmented into arthritis, chronic tendinitis, and bone repair & regeneration. Similarly, the dermatology segment is further segmented into androgenic alopecia and plastic surgery. The dermatology application segment is expected to grow at the highest CAGR from 2016 to 2021, owing to increase in the number of cosmetic procedures.
Based on end user, the plasma therapy market is segmented into hospitals & clinics and research institutions. The hospitals & clinics segment is estimated to account for the largest share of the global market in 2016. Rise in healthcare spending has resulted in the increasing use of PRP in hospitals & clinics.
To Know More @ https://tinyurl.com/y7nznvg5
No comments:
Post a Comment